Form 4: Amphenol Executive Plans $11.36M Stock Sale

Sentiment:

Insider Transaction Report


Amphenol's President of CS Division, William J. Doherty, has filed a Form 4 indicating a future planned exercise of stock options and subsequent sale of 80,000 shares of Class A Common Stock.

Summary

  • William J. Doherty, President of Amphenol's CS Division, filed a Form 4 reporting a planned transaction for December 2, 2025.
  • The transaction involves the exercise of 80,000 stock options at an exercise price of $33.295 per share.
  • Concurrently, 80,000 shares of Class A Common Stock acquired from the option exercise will be sold.
  • The shares are planned to be sold at a weighted average price of $142.0029 per share, with trades ranging from $141.9450 to $142.1900.
  • This transaction is being made pursuant to a Rule 10b5-1(c) plan.
  • Following these transactions, Mr. Doherty will beneficially own 0 shares of Class A Common Stock directly and 106,000 derivative securities (stock options).

Sentiment

Score: 6

Explanation: The transaction represents a planned monetization of executive compensation through stock options, which is a routine event. The high sale price relative to the exercise price is positive for the executive. The pre-planned nature under Rule 10b5-1 mitigates concerns about opportunistic selling.

Positives

  • The planned sale price of $142.0029 per share is significantly higher than the option exercise price of $33.295, indicating substantial value realization for the executive.
  • The transaction is pre-planned under a Rule 10b5-1(c) plan, which suggests it is not based on new, non-public information.

Negatives

  • A planned sale of 80,000 shares by a high-ranking executive could be perceived as a reduction in direct equity exposure, although the executive retains 106,000 derivative securities.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

  • Shareholders: The planned sale by an executive could be viewed with slight caution, but the 10b5-1 plan and retention of significant derivative holdings mitigate concerns about a lack of confidence in the company. It is a common part of executive compensation.

Key Dates

DateDescription
05/20/2022Date stock options became exercisable.
12/02/2025Planned transaction date for option exercise and stock sale.
05/20/2031Expiration date of the stock options.

Recommendation

hold

This Form 4 reports a future, pre-planned transaction under a 10b5-1 plan, which is a common practice for executives to diversify holdings and manage compensation. While it involves a significant number of shares, the planned nature and the executive's continued holding of derivative securities suggest it is not a signal of negative sentiment towards the company's future prospects. Therefore, it does not warrant a change in investment recommendation based solely on this filing.

Keywords

Amphenol, APH, insider trading, Form 4, stock options, executive compensation, stock sale, William J. Doherty, 10b5-1 plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.